TWST
Income statement / Annual
Last year (2024), Twist Bioscience Corporation's total revenue was $312.97 M,
an increase of 27.69% from the previous year.
In 2024, Twist Bioscience Corporation's net income was -$208.73 M.
See Twist Bioscience Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
| Operating Revenue |
$312.97 M
|
$245.11 M
|
$203.57 M
|
$132.33 M
|
$90.10 M
|
$54.39 M
|
$25.43 M
|
$10.77 M
|
$2.27 M
|
| Cost of Revenue |
$179.63 M |
$155.38 M |
$119.33 M |
$80.62 M |
$61.41 M |
$47.43 M |
$32.19 M |
$24.02 M |
$9.42 M |
| Gross Profit |
$133.35 M |
$89.73 M |
$84.24 M |
$51.71 M |
$28.69 M |
$6.96 M |
-$6.76 M |
-$13.25 M |
-$7.15 M |
| Gross Profit Ratio |
0.43 |
0.37 |
0.41 |
0.39 |
0.32 |
0.13 |
-0.27 |
-1.23 |
-3.15 |
| Research and Development
Expenses |
$90.85 M
|
$106.89 M
|
$120.31 M
|
$69.07 M
|
$43.01 M
|
$35.68 M
|
$20.35 M
|
$19.17 M
|
$18.23 M
|
| General & Administrative
Expenses |
$0.00
|
$186.84 M
|
$210.55 M
|
$133.40 M
|
$102.07 M
|
$78.83 M
|
$42.55 M
|
$25.96 M
|
$18.07 M
|
| Selling & Marketing
Expenses |
$0.00
|
$2.90 M
|
$2.40 M
|
$2.50 M
|
$1.20 M
|
$1.30 M
|
$900,000.00
|
$100,000.00
|
$200,000.00
|
| Selling, General &
Administrative Expenses |
$218.40 M
|
$189.74 M
|
$212.95 M
|
$135.90 M
|
$103.27 M
|
$80.13 M
|
$43.45 M
|
$26.06 M
|
$18.27 M
|
| Other Expenses |
$44.93 M |
$10.26 M |
-$1.09 M |
-$1.37 M |
-$182,000.00 |
-$265,000.00 |
-$121,000.00 |
-$55,000.00 |
$73,000.00 |
| Operating Expenses |
$354.18 M |
$306.89 M |
$333.26 M |
$204.97 M |
$146.27 M |
$115.81 M |
$63.80 M |
$45.23 M |
$36.50 M |
| Cost And Expenses |
$533.81 M |
$462.27 M |
$452.59 M |
$285.59 M |
$207.68 M |
$163.24 M |
$95.99 M |
$69.25 M |
$45.93 M |
| Interest Income |
$15.34 M |
$14.37 M |
$3.06 M |
$435,000.00 |
$1.50 M |
$3.03 M |
$999,000.00 |
$412,000.00 |
$241,000.00 |
| Interest Expense |
$29,000.00 |
$5,000.00 |
$80,000.00 |
$367,000.00 |
$787,000.00 |
$1.29 M |
$1.31 M |
$905,000.00 |
$746,000.00 |
| Depreciation &
Amortization |
$31.43 M
|
$29.31 M
|
$36.64 M
|
$11.99 M
|
$6.68 M
|
$6.31 M
|
$5.73 M
|
$5.02 M
|
$4.23 M
|
| EBITDA |
-$176.71 M
|
-$174.15 M
|
-$191.55 M
|
-$143.91 M
|
-$132.09 M
|
-$99.77 M
|
-$63.95 M
|
-$53.10 M
|
-$39.11 M
|
| EBITDA Ratio |
-0.56 |
-0.71 |
-1.21 |
-1.17 |
-1.29 |
-1.95 |
-2.52 |
-4.93 |
-17.24 |
| Operating Income Ratio
|
-0.71
|
-0.89
|
-1.22
|
-1.16
|
-1.3
|
-2
|
-2.77
|
-5.43
|
-19.24
|
| Total Other
Income/Expenses Net |
$12.67 M
|
$13.69 M
|
$6.50 M
|
-$1.30 M
|
$530,000.00
|
$1.47 M
|
-$435,000.00
|
-$548,000.00
|
-$432,000.00
|
| Income Before Tax |
-$208.17 M |
-$203.47 M |
-$228.27 M |
-$154.03 M |
-$139.55 M |
-$107.38 M |
-$70.99 M |
-$59.03 M |
-$44.09 M |
| Income Before Tax Ratio
|
-0.67
|
-0.83
|
-1.12
|
-1.16
|
-1.55
|
-1.97
|
-2.79
|
-5.48
|
-19.43
|
| Income Tax Expense |
$560,000.00 |
$1.15 M |
-$10.41 M |
-$1.93 M |
$382,000.00 |
$292,000.00 |
$242,000.00 |
$280,000.00 |
$819,000.00 |
| Net Income |
-$208.73 M |
-$204.62 M |
-$217.86 M |
-$152.10 M |
-$139.93 M |
-$107.67 M |
-$71.24 M |
-$59.31 M |
-$44.09 M |
| Net Income Ratio |
-0.67 |
-0.83 |
-1.07 |
-1.15 |
-1.55 |
-1.98 |
-2.8 |
-5.51 |
-19.43 |
| EPS |
-3.6 |
-3.6 |
-4.04 |
-3.15 |
-3.57 |
-3.92 |
-2.68 |
-3.16 |
-2.35 |
| EPS Diluted |
-3.6 |
-3.6 |
-4.04 |
-3.15 |
-3.57 |
-3.92 |
-2.68 |
-3.16 |
-2.35 |
| Weighted Average Shares
Out |
$58.02 M
|
$56.89 M
|
$53.89 M
|
$48.25 M
|
$39.19 M
|
$27.46 M
|
$26.61 M
|
$18.78 M
|
$18.78 M
|
| Weighted Average Shares
Out Diluted |
$58.02 M
|
$56.89 M
|
$53.89 M
|
$48.25 M
|
$39.19 M
|
$27.46 M
|
$26.61 M
|
$18.78 M
|
$18.78 M
|
| Link |
|
|
|
|
|
|
|
|
|
